Pain relief after esophageal lesion removal using a numbing medication
Part of Digestive system, Pain clinical trials.
This trial tests whether injecting a long-acting numbing medicine (levobupivacaine) into the esophagus after removing a large lesion can reduce pain. If you're scheduled for this procedure, you may experience less discomfort afterward.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a visible lesion in your esophagus that is at least 20 millimeters (about 0.8 inches) wide.
- You are scheduled to have the lesion removed using a procedure called endoscopic submucosal dissection (ESD).
- You are able to give your informed consent to participate.
- You do not have any condition that would make the numbing medicine unsafe or the pain difficult to assess.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of nerve blocks (paravertebral and epidural) to see which provides better pain relief after esophagectomy. The goal is to find the safest and most effective way to manage pain for patients undergoing this surgery.
This study compares two ways to manage pain after minimally invasive esophagectomy: a paravertebral catheter (a small tube near the spine) versus epidural analgesia (a tube in the back). The goal is to see which method provides better pain relief with fewer side effects.
This trial is testing if a special numbing medicine called liposomal bupivacaine, given as a nerve block during surgery, can help reduce pain after laparoscopic procedures like gallbladder removal or hernia repair. It might help you feel better with less need for strong painkillers.
This trial tests a pain-control method (using an epidural/nerve pain-block through the back, called neuraxial anesthesia) for people having minimally invasive esophagus removal surgery. It may help reduce pain after surgery and improve comfort during recovery.
This trial tests whether a long-lasting numbing shot (liposomal bupivacaine) works better than a regular numbing shot (plain bupivacaine) for pain after minimally invasive chest surgery. It may help you have less post-surgery pain and potentially use less pain medication.
This study tests whether a long-lasting numbing medicine (liposomal bupivacaine) injected near the spine can better control pain after lung surgery. It compares this to a standard numbing medicine, and aims to help patients recover with less pain after surgery.
Hear when a new Endoscopic Submucosal Dissection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.